13/89/03 - Evidence-based diagnosis and management of upper digestive, hepato-biliary, and pancreatic disorders
Research type: Evidence Synthesis
Start date: May 2014
Publication date: November 2017
Cost: £299,996.00
Contractor: University College London
Publications
- Amylase in drain fluid for the diagnosis of pancreatic leak in post -pancreatic resection
- Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer
- Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer
- Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis
- Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgery
- Eradication therapy for peptic ulcer disease in Helicobacter pylori positive people
- Imaging modalities for characterising focal pancreatic lesions
- Interventions for hereditary haemochromatosis
- Interventions for necrotising pancreatitis
- Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults
- Laparoscopic versus open distal pancreatectomy for pancreatic cancer
- Laparoscopic versus open gastrectomy for gastric cancer
- Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
- Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis
- Management of people with early - or very early -stage hepatocellular carcinoma
- Management of people with intermediate -stage hepatocellular carcinoma
- Management strategies for pancreatic pseudocysts
- Medical versus surgical treatment for refractory or recurrent peptic ulcer
- Non-surgical versus surgical treatment for oesophageal cancer
- Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease)
- Pharmacological interventions for acute hepatitis B infection
- Pharmacological interventions for acute hepatitis C infection
- Pharmacological interventions for acute pancreatitis
- Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)
- Pharmacological interventions for primary biliary cholangitis
- Pharmacological interventions for primary sclerosing cholangitis
- Pregabalin for decreasing pancreatic pain in chronic pancreatitis
- Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis
- Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis